Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Karen W Hoover

Biographic Data

ID6057245
NAMEKaren W Hoover
GIVEN NAMESKaren W
FAMILY NAMEHoover
SIGNATUREHOOVER K W
AFFILIATIONSCenters for Disease Control and Prevention
ORCID0000-0003-4942-7905
VERIFIEDYes
TOTAL WORKS13
TOTAL CITATIONS2
AUTHOR COUNT13
EDITOR COUNT0
FIRST PUBLICATION YEAR2012
LATEST PUBLICATION YEAR2026
H-INDEX1
  • Patient perspectives on point-of-care HIV nucleic acid tests for viral load monitoring in Seattle, WA

    Open Access•Lisa A Niemann, Maggie Murphy et al.•ARTICLE•AIDS Care•2026

    INTRODUCTION: Viral load (VL) monitoring is a critical component of HIV care for people with HIV (PWH); however, laboratory VL tests often take days to return results. Point-of-care nucleic acid tests (POC NAT s) could provide faster VL monitoring for PWH in the United States (US). METHODS: Participants receiving semi-quantitative POC NAT via the Greater Access and Impact with NAT (GAIN) Study were invited to participate in surveys and in-depth i…

  • Low HIV Preexposure Prophylaxis Coverage Among Women

    Karen W Hoover, Weiming Zhu et al.•ARTICLE•American Journal of Public Health•2025•References: 10

    Objectives. HIV preexposure prophylaxis (PrEP) use has increased since its US Food and Drug Administration approval in 2012. Our objective was to describe trends in PrEP use by US women. Methods. Using national pharmacy and HIV surveillance data, we calculated the PrEP-to-diagnosis ratio (PDR), a measure of PrEP prescriptions each year compared with HIV diagnoses the previous year, for women from 2017 to 2023. We also calculated PDRs in 2023 for …

  • Achieving the “Ending the HIV Epidemic in the U.S.” incidence reduction goals among at-risk populations in the South

    Open Access•Deven T Hamilton, Karen W Hoover et al.•ARTICLE•BMC Public Health•2023

    Our analysis indicates that it is possible to reach EHE goals. The largest reductions in HIV incidence can be achieved by increasing ART coverage among MSM and all race groups benefit regardless of differences in ART initiation by race. Improving ART coverage to > 90% should be prioritized with a particular emphasis on reaching NHB MSM. Such a focus will reduce the largest number of incident cases, reduce racial HIV incidence disparities among bo…

  • Benefits of Frequent HIV Testing in the THRIVE Demonstration Project

    Anne A Kimball, Anne Kimball et al.•ARTICLE•American Journal of Public Health•2023•References: 10

    Objectives. To describe HIV testing among clients in the Targeted Highly Effective Interventions to Reverse the HIV Epidemic (THRIVE) demonstration project and evaluate testing frequency. Methods. We identified factors associated with an average testing frequency of 180 days or less compared with more than 180 days using adjusted Poisson regression models. We performed the Kaplan–Meier survival analysis to compare time to diagnosis by testing fre…

  • The Effect of Navigation on Linkage to a PrEP Provider Among PrEP-Eligible Men who have Sex with Men in a U.S. Demonstration Project

    Open Access•Anne Kimball, Weiming Zhu et al.•ARTICLE•AIDS and Behavior•2022

  • HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016

    Open Access•Ya-Lin A Huang, Weiming Zhu et al.•ARTICLE•MMWR. Surveillance Summaries•2018

    Preexposure prophylaxis (PrEP) with a daily, oral pill containing antiretroviral drugs is highly effective in preventing acquisition of human immunodeficiency virus (HIV) infection (1-4). The combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is the only medication approved by the Food and Drug Administration (FDA) for PrEP. PrEP is indicated for men and women with sexual or injection drug use behaviors that increase their…

  • Antiretroviral treatment among commercially insured persons living with HIV in an era of universal treatment in the United States – 2012–2014

    Kashif Iqbal, Ya-Lin A Huang et al.•ARTICLE•AIDS Care•2018

    In 2012, antiretroviral (ARV) treatment guidelines expanded indications and recommended antiretroviral treatment for all HIV-infected persons in the United States, regardless of CD4 cell count. This analysis describes ARV prescriptions among commercially insured HIV-infected adults from 2012 to 2014. We analyzed persons aged 18-64 years from 2012 to 2014 Truven Health MarketScan Commercial Claims and Encounters® database. We identified HIV-infect…

  • Improving HIV Preexposure Prophylaxis Implementation for Women

    Open Access•Erin L P Bradley, Karen W Hoover•ARTICLE•Women s Health Issues•2018

  • HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015

    Philip J Peters, Pamela Pontones et al.•ARTICLE•New England Journal of Medicine•2016

    BACKGROUND: In January 2015, a total of 11 new diagnoses of human immunodeficiency virus (HIV) infection were reported in a small community in Indiana. We investigated the extent and cause of the outbreak and implemented control measures. METHODS: We identified an outbreak-related case as laboratory-confirmed HIV infection newly diagnosed after October 1, 2014, in a person who either resided in Scott County, Indiana, or was named by another case …

  • Willingness to Use Health Insurance at a Sexually Transmitted Disease Clinic

    William S Pearson, Ryan Cramer et al.•ARTICLE•American Journal of Public Health•2016•References: 10

    Objectives. To survey patients of publicly funded sexually transmitted disease (STD) clinics across the United States about their willingness to use health insurance for their visit. Methods. In 2013, we identified STD clinics in 21 US metropolitan statistical areas with the highest rates of chlamydia, gonorrhea, and syphilis according to Centers for Disease Control and Prevention surveillance reports. Patients attending the identified STD clinic…

  • Continuing Need for Sexually Transmitted Disease Clinics After the Affordable Care Act

    Karen W Hoover, Bradley W Parsell et al.•ARTICLE•American Journal of Public Health•2015•Cited by: 2•References: 17

    Objectives. We assessed the characteristics of sexually transmitted disease (STD) clinic patients, their reasons for seeking health services in STD clinics, and their access to health care in other venues. Methods. In 2013, we surveyed persons who used publicly funded STD clinics in 21 US cities with the highest STD morbidity. Results. Of the 4364 STD clinic patients we surveyed, 58.5% were younger than 30 years, 72.5% were non-White, and 49.9% w…

  • Ectopic Pregnancy Among American Indian and Alaska Native Women, 2002–2009

    Open Access•Lori de Ravello, Arianne M Folkema et al.•ARTICLE•Maternal and Child Health Journal•2014

  • Higher Yet Suboptimal Chlamydia Testing Rates at Community Health Centers and Outpatient Clinics Compared With Physician Offices

    Jeffrey M Eugene, Karen W Hoover et al.•ARTICLE•American Journal of Public Health•2012•References: 10

    To assess chlamydia testing in women in community health centers, we analyzed data from national surveys of ambulatory health care. Women with chlamydial symptoms were tested at 16% of visits, and 65% of symptomatic women were tested if another reproductive health care service (pelvic examination, Papanicolaou test, or urinalysis) was performed. Community health centers serve populations with high sexually transmitted disease rates and fill gaps …

  • Continuing Need for Sexually Transmitted Disease Clinics After the Affordable Care Act

    Karen W Hoover, Bradley W Parsell et al.•ARTICLE•American Journal of Public Health•2015•Cited by: 2•References: 17

    Objectives. We assessed the characteristics of sexually transmitted disease (STD) clinic patients, their reasons for seeking health services in STD clinics, and their access to health care in other venues. Methods. In 2013, we surveyed persons who used publicly funded STD clinics in 21 US cities with the highest STD morbidity. Results. Of the 4364 STD clinic patients we surveyed, 58.5% were younger than 30 years, 72.5% were non-White, and 49.9% w…

  • Higher Yet Suboptimal Chlamydia Testing Rates at Community Health Centers and Outpatient Clinics Compared With Physician Offices

    Jeffrey M Eugene, Karen W Hoover et al.•ARTICLE•American Journal of Public Health•2012•References: 10

    To assess chlamydia testing in women in community health centers, we analyzed data from national surveys of ambulatory health care. Women with chlamydial symptoms were tested at 16% of visits, and 65% of symptomatic women were tested if another reproductive health care service (pelvic examination, Papanicolaou test, or urinalysis) was performed. Community health centers serve populations with high sexually transmitted disease rates and fill gaps …

  • Ectopic Pregnancy Among American Indian and Alaska Native Women, 2002–2009

    Open Access•Lori de Ravello, Arianne M Folkema et al.•ARTICLE•Maternal and Child Health Journal•2014

  • Continuing Need for Sexually Transmitted Disease Clinics After the Affordable Care Act

    Karen W Hoover, Bradley W Parsell et al.•ARTICLE•American Journal of Public Health•2015•Cited by: 2•References: 17

    Objectives. We assessed the characteristics of sexually transmitted disease (STD) clinic patients, their reasons for seeking health services in STD clinics, and their access to health care in other venues. Methods. In 2013, we surveyed persons who used publicly funded STD clinics in 21 US cities with the highest STD morbidity. Results. Of the 4364 STD clinic patients we surveyed, 58.5% were younger than 30 years, 72.5% were non-White, and 49.9% w…

  • HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014–2015

    Philip J Peters, Pamela Pontones et al.•ARTICLE•New England Journal of Medicine•2016

    BACKGROUND: In January 2015, a total of 11 new diagnoses of human immunodeficiency virus (HIV) infection were reported in a small community in Indiana. We investigated the extent and cause of the outbreak and implemented control measures. METHODS: We identified an outbreak-related case as laboratory-confirmed HIV infection newly diagnosed after October 1, 2014, in a person who either resided in Scott County, Indiana, or was named by another case …

  • Willingness to Use Health Insurance at a Sexually Transmitted Disease Clinic

    William S Pearson, Ryan Cramer et al.•ARTICLE•American Journal of Public Health•2016•References: 10

    Objectives. To survey patients of publicly funded sexually transmitted disease (STD) clinics across the United States about their willingness to use health insurance for their visit. Methods. In 2013, we identified STD clinics in 21 US metropolitan statistical areas with the highest rates of chlamydia, gonorrhea, and syphilis according to Centers for Disease Control and Prevention surveillance reports. Patients attending the identified STD clinic…

  • HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016

    Open Access•Ya-Lin A Huang, Weiming Zhu et al.•ARTICLE•MMWR. Surveillance Summaries•2018

    Preexposure prophylaxis (PrEP) with a daily, oral pill containing antiretroviral drugs is highly effective in preventing acquisition of human immunodeficiency virus (HIV) infection (1-4). The combination of tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is the only medication approved by the Food and Drug Administration (FDA) for PrEP. PrEP is indicated for men and women with sexual or injection drug use behaviors that increase their…

  • Antiretroviral treatment among commercially insured persons living with HIV in an era of universal treatment in the United States – 2012–2014

    Kashif Iqbal, Ya-Lin A Huang et al.•ARTICLE•AIDS Care•2018

    In 2012, antiretroviral (ARV) treatment guidelines expanded indications and recommended antiretroviral treatment for all HIV-infected persons in the United States, regardless of CD4 cell count. This analysis describes ARV prescriptions among commercially insured HIV-infected adults from 2012 to 2014. We analyzed persons aged 18-64 years from 2012 to 2014 Truven Health MarketScan Commercial Claims and Encounters® database. We identified HIV-infect…

  • Improving HIV Preexposure Prophylaxis Implementation for Women

    Open Access•Erin L P Bradley, Karen W Hoover•ARTICLE•Women s Health Issues•2018

  • The Effect of Navigation on Linkage to a PrEP Provider Among PrEP-Eligible Men who have Sex with Men in a U.S. Demonstration Project

    Open Access•Anne Kimball, Weiming Zhu et al.•ARTICLE•AIDS and Behavior•2022

  • Achieving the “Ending the HIV Epidemic in the U.S.” incidence reduction goals among at-risk populations in the South

    Open Access•Deven T Hamilton, Karen W Hoover et al.•ARTICLE•BMC Public Health•2023

    Our analysis indicates that it is possible to reach EHE goals. The largest reductions in HIV incidence can be achieved by increasing ART coverage among MSM and all race groups benefit regardless of differences in ART initiation by race. Improving ART coverage to > 90% should be prioritized with a particular emphasis on reaching NHB MSM. Such a focus will reduce the largest number of incident cases, reduce racial HIV incidence disparities among bo…

  • Benefits of Frequent HIV Testing in the THRIVE Demonstration Project

    Anne A Kimball, Anne Kimball et al.•ARTICLE•American Journal of Public Health•2023•References: 10

    Objectives. To describe HIV testing among clients in the Targeted Highly Effective Interventions to Reverse the HIV Epidemic (THRIVE) demonstration project and evaluate testing frequency. Methods. We identified factors associated with an average testing frequency of 180 days or less compared with more than 180 days using adjusted Poisson regression models. We performed the Kaplan–Meier survival analysis to compare time to diagnosis by testing fre…

  • Low HIV Preexposure Prophylaxis Coverage Among Women

    Karen W Hoover, Weiming Zhu et al.•ARTICLE•American Journal of Public Health•2025•References: 10

    Objectives. HIV preexposure prophylaxis (PrEP) use has increased since its US Food and Drug Administration approval in 2012. Our objective was to describe trends in PrEP use by US women. Methods. Using national pharmacy and HIV surveillance data, we calculated the PrEP-to-diagnosis ratio (PDR), a measure of PrEP prescriptions each year compared with HIV diagnoses the previous year, for women from 2017 to 2023. We also calculated PDRs in 2023 for …

  • Patient perspectives on point-of-care HIV nucleic acid tests for viral load monitoring in Seattle, WA

    Open Access•Lisa A Niemann, Maggie Murphy et al.•ARTICLE•AIDS Care•2026

    INTRODUCTION: Viral load (VL) monitoring is a critical component of HIV care for people with HIV (PWH); however, laboratory VL tests often take days to return results. Point-of-care nucleic acid tests (POC NAT s) could provide faster VL monitoring for PWH in the United States (US). METHODS: Participants receiving semi-quantitative POC NAT via the Greater Access and Impact with NAT (GAIN) Study were invited to participate in surveys and in-depth i…

Medicine (12 works) · HIV/AIDS Research and Interventions (10 works) · Family medicine (9 works) · HIV, Drug Use, Sexual Risk (8 works) · Human immunodeficiency virus (HIV) (8 works) · Public health (7 works) · Men who have sex with men (6 works) · Pre-exposure prophylaxis (6 works) · Demography (5 works) · Environmental health (5 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae